Evaluation of Infliximab and Anti-infliximab LISA-TRACKER Immunoassays for the Therapeutic Drug Monitoring of SB2 Infliximab Biosimilar

Jentzer, A; Berger, AE; Labetoulle, R; Haccourt, A; Roblin, X; Paul, S

Paul, S (reprint author), Hosp St Etienne, Lab Immunol & Immunomonitoring, Clin Invest Ctr, Inserm 1408,GIMAP EA3064, St Etienne, France.

THERAPEUTIC DRUG MONITORING, 2018; 40 (6): 749

Abstract

Background: SB2, an infliximab (IFX) biosimilar to the reference infliximab (R.I.) product (Remicade), received approval in the European Union for all......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索